Question

In: Operations Management

Should insurance companies spread the risk amongst all of their policyholders as is often done in...

Should insurance companies spread the risk amongst all of their policyholders as is often done in automobile insurance or is there better way to deal with the matter of risk? Describe how this might be accomplished and argue why this is a good or bad practice.

Make at least 100-150 words, thank you.

Solutions

Expert Solution

Insurance companies should not spread the risk evenly among all the policy holders, because it brings generalization and premium of the policy also increases for those who have the lowest risk quotient. Further, there is no incentive for the people with lower risk and it increases the number of claims. So, there should be a better way to deal with it. As a part of it, there should be different groups of the policy holders on the basis of their risk profiles. A risk of higher level, should be aligned to the policy holders with higher level of risk profile and these policy holders should pay higher premium. It is a good practice, because it helps in encouraging policy holders to be sensible, avoid risky behavior and remain safe. As a result, they will be able to pay lower premium in the future and companies will have lower number of claims. So, this policy will be beneficial to insurance providers as well as policy holders.


Related Solutions

Do you think there are situations when insurances companies should not spread the risk of loss?
Do you think there are situations when insurances companies should not spread the risk of loss?
A property and casualty insurance company categorizes its policyholders into three groups: low risk, medium risk,...
A property and casualty insurance company categorizes its policyholders into three groups: low risk, medium risk, or high risk. 25% of the policyholders are low risk and 30% are high risk. The high risk policyholders are three times as likely as medium risk policyholders to file an insurance claim and the medium risk policyholders are twice as likely as the low risk policyholders to file an insurance claim. Determine the proportion of the insurance claims filed by medium risk policyholders.
Travelers Insurance is a publicly traded entity which assumes the risk of its policyholders. It can...
Travelers Insurance is a publicly traded entity which assumes the risk of its policyholders. It can fairly easily raise capital for operating expenditures and is governed by a board of directors. Travelers is a A) mutual insurance company. B) a Name at Lloyds of London. C) stock insurance company. D) a fraternal insurance company
Because insurance companies must maintain adequate reserves to pay policyholders, they typically place most of their...
Because insurance companies must maintain adequate reserves to pay policyholders, they typically place most of their investments in: Fixed Income Instruments i.e. bonds Hedge Funds Large Cap companies on the NYSE Foreign Investments 2. Prior to the IPO, the seller would have probably sought the services, and funds, of a venture capital firm. In exchange for the funds, VC firms typically: Require at least one seat on the Board of Directors Take a very active stance in the operation of...
what is the tools of risk management for insurance companies ?
what is the tools of risk management for insurance companies ?
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose...
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average length of time in months patients live once starting the treatment. Two researchers each follow a different set of 40 AIDS patients from the start of treatment until their deaths. The following data (in months) are collected....
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose...
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average length of time in months patients live once starting the treatment. Two researchers each follow a different set of 40 AIDS patients from the start of treatment until their deaths. The following data (in months) are collected....
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose...
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average length of time in months patients live once starting the treatment. Two researchers each follow a different set of 40 AIDS patients from the start of treatment until their deaths. The following data (in months) are collected....
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose...
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average (mean) length of time in months patients live once starting the treatment. Two researchers each follow a different set of 40 AIDS patients from the start of treatment until their deaths. The following data (in months) are...
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose...
Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average (mean) length of time in months patients live once starting the treatment. Two researchers each follow a different set of 40 AIDS patients from the start of treatment until their deaths. The following data (in months) are...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT